Treatment

Liraglutide clinical trials

Active studies that list Liraglutide as an intervention or treatment.

4active studies

2recruiting now

10countries represented

32largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 1

ObesityCondition

Liraglutide, Oral SemaglutideTreatment

United States1 locations

Novo Nordisk A/SSponsor

Updated 2026-07-21 · NCT07225816See eligibility →

Recruiting nowPhase 4

Type 2 Diabetes Patients, Overweight and ObesityCondition

Liraglutide, insulin glargineTreatment

China1 locations

The First Affiliated Hospital of Xiamen UniversitySponsor

Updated 2025-01-13 · NCT03087032See eligibility →

Active, not recruitingPhase 3

ObesityCondition

Liraglutide, PlaceboTreatment

Belgium, India32 locations

Novo Nordisk A/SSponsor

Updated 2026-07-09 · NCT04775082See eligibility →

Active, not recruitingNot applicable

ObesityCondition

Semaglutide, Phentermine-Topiramate combinationTreatment

United States2 locations

Louisiana State University Health Sciences Center in New OrleansSponsor

Updated 2025-09-09 · NCT05756764See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.